Abiopharma

🔍 Meisner Derek M (Executive)

Company: Acumen Pharmaceuticals, Inc. (ABOS)

Report Date: 2026-03-06

Detailed Transactions and Holdings:

• Acquired 2,090 shares of Common Stock at $1.85 per share (Direct)
  Date: 2026-03-06 | Code: M | equity_swap_involved: 0 | shares_owned_after: 176,089.00 | transaction_form_type: 4
• Sold 2,090 shares of Common Stock at $3.26 per share (Direct)
  Date: 2026-03-06 | Code: S | equity_swap_involved: 0 | shares_owned_after: 173,999.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 2,090 shares of Employee Stock Option (right to buy) at $1.85 per share (Derivative)
  Date: 2026-03-06 | Code: M | Expires: 2035-01-06 | equity_swap_involved: 0 | shares_owned_after: 71,048.00 | transaction_form_type: 4 | Footnotes: F2

Footnotes:

• F1: The reported sales occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 29, 2025.
• F2: The shares subject to the option will vest in 48 equal monthly installments such that the option is fully vested on the fourth anniversary of the date of grant, subject to the Reporting Person's continuous service through each such vesting date.